close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STERIS plc (Ireland) Ordinary Shares (NY:STE)

254.75 -1.52 (-0.59%)
Delayed Quote Updated: 10:17 AM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about STERIS plc (Ireland) Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
What STERIS (STE) Said on Its Q2 Earnings Call ↗
STERIS (NYSE:STE) raised its fiscal 2027 earnings outlook after reporting higher second-quarter revenue and profit, as tariff refunds helped expand margins and strong Life Sciences equipment shipments... 
Via MarketBeat
Topics Earnings Economy World Trade
News headline image
5 revealing analyst questions from STERIS’s Q3 CY2026 earnings call
STERIS delivered a quarter that met Wall Street’s expectations, driven by strong underlying demand in its Healthcare and Life Sciences segments, as well as a... 
Via StockStory
Topics Earnings Economy World Trade
News headline image
STERIS (STE) Q2 2027 Earnings Call Transcript ↗
Restructuring charges and a pending Xodus Medical deal headline a strong quarter. 
Via The Motley Fool
Topics Earnings World Trade
STERIS (NYSE:STE): A Quality Investment Built for Long-Term Compounding ↗
Via Chartmill
STERIS (NYSE:STE) Beats Estimates but Keeps Outlook, Sending Shares Down ↗
Via Chartmill
STERIS PLC (NYSE:STE): A Quality Investing Standout ↗
Via Chartmill
S&P 500 Top Movers: AppLovin Leads Today's Session With 29.19% Gain ↗
Via Chartmill
Topics Stocks
News headline image
STE Q3 CY2026 deep dive: tariff refunds and consumables growth fuel guidance raise
Medical equipment and services company Steris (NYSE:STE) reported calendar Q3 2026 (fiscal Q2 2027) results topping the market’s revenue expectations, with s... 
Via StockStory
Topics Economy World Trade
News headline image
STERIS (NYSE:STE) posts better-than-expected sales in Q3 CY2026, stock soars
Medical equipment and services company Steris (NYSE:STE) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q2 2027), with revenue up 8.8% ye... 
Via StockStory
News headline image
AdaptHealth, Align Technology, Acadia Healthcare, DexCom, and STERIS shares are soaring, what you need to know
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat... 
Via StockStory
News headline image
STERIS (STE) reports earnings tomorrow: what to expect
Medical equipment and services company Steris (NYSE:STE) will be announcing earnings results this Wednesday after the bell. Here’s what you need to know. STE... 
Via StockStory
Topics Artificial Intelligence
Discover which S&P500 stocks are making waves on Monday. ↗
Via Chartmill
News headline image
2 S&P 500 Stocks to Own for Decades and 1 We Ignore
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Energy Stocks
News headline image
3 Healthcare Stocks That Fall Short
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have... 
Via StockStory
News headline image
3 Mid-Cap Stocks with Open Questions
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Brush Off
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
Recent Report Shows That Rep. Jared Moskowitz Sold Up to $30K Worth of Steris Stock ↗
An official report on August 27, 2026 reveals Representative Jared Moskowitz's recent sale of Steris (NYSE:STE) stock, valued between $2,002 and $30,000. The transaction took place on July 13, 2026, as... 
Via Benzinga
News headline image
3 Reasons STE is Risky and 1 Stock to Buy Instead
Over the past six months, STERIS’s shares (currently trading at $232.53) have posted a disappointing 7.4% loss, well below the S&P 500’s 12.9% gain. This mig... 
Via StockStory
Topics Stocks
News headline image
Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how surgical equipment & c... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
STERIS Q1 Earnings Call Highlights ↗
STERIS (NYSE:STE) reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry... 
Via MarketBeat
Topics Earnings Economy World Trade
News headline image
STERIS (NYSE:STE) Posts Q2 CY2026 Sales In Line With Estimates
Medical equipment and services company Steris (NYSE:STE) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.3% year on year to $1.49 billio... 
Via StockStory
News headline image
STERIS (STE) To Report Earnings Tomorrow: Here Is What To Expect
Medical equipment and services company Steris (NYSE:STE) will be announcing earnings results this Wednesday after the bell. Here’s what you need to know. STE... 
Via StockStory
News headline image
1 Healthcare Stock to Research Further and 2 We Avoid
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
2 S&P 500 Stocks to Keep an Eye On and 1 We Avoid
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec... 
Via StockStory
Topics Stocks
News headline image
STERIS (STE): Buy, Sell, or Hold Post Q1 Earnings?
STERIS’s stock price has taken a beating over the past six months, shedding 20.4% of its value and falling to $202.39 per share. This might have investors co... 
Via StockStory
News headline image
3 Cash-Producing Stocks We Think Twice About
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
Via StockStory
News headline image
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 That Underwhelm
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
CBIZ Stock Is Down 60%. Here's What a $21.7 Million Exit Could Mean ↗
CBIZ offers accounting, insurance, and advisory services to small and mid-sized clients in North America across three core segments. 
Via The Motley Fool
Topics Regulatory Compliance Retirement
News headline image
The 5 Most Interesting Analyst Questions From STERIS’s Q1 Earnings Call
STERIS delivered Q1 results that met Wall Street’s revenue expectations, with the market reacting positively to the company’s performance. Management pointed... 
Via StockStory
Topics Earnings Economy World Trade
News headline image
STERIS Q4 Earnings Call Highlights ↗
STERIS (NYSE:STE) reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains,... 
Via MarketBeat
Topics Earnings Economy World Trade
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.